caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1013229897

Sara Zelinskas

PodiatryVirginia Beach, VAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Sara Zelinskas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 12 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SENTARA HOSPITALS81203
BON SECOURS DEPAUL MEDICAL CENTER LLC2652
FLOR, CARL2159
David Holt
Family Practice · Virginia Beach, VA
1588
COHEN, EDITH1218
KNIGHT, HERBERT1250
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
SENTARA HOSPITALS125357
SENTARA HOSPITALS105251
Robert Sullivan
Podiatry · Virginia Beach, VA
101195
SENTARA HOSPITALS97243
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
94197
SENTARA PRINCESS ANNE HOSPITAL60170
BON SECOURS DEPAUL MEDICAL CENTER LLC2653
NPI 17503849541843
FLOR, CARL1849
Dominion Pathology Laboratories Pc
Clinical Laboratory · Norfolk, VA
1324
David Holt
Family Practice · Virginia Beach, VA
1291
Chan Nguyen
Diagnostic Radiology · Virginia Beach, VA
1116
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
28
Beneficiaries
—
Total drug cost
$279
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Gabapentin17 claims
Triamcinolone Acetonide11 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
80.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.